Modulation of cardiac stem cell characteristics by metoprolol in hypertensive heart disease

Sherin Saheera1, Ajay Godwin Potnuri1, Renuka R Nair2

  • 1Division of Cellular and Molecular Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Thiruvananthapuram, Kerala, 695011, India.

Insights

Metoprolol treatment improved cardiac stem cell (CSC) function in spontaneously hypertensive rats (SHRs). The drug enhanced CSC migration, proliferation, and survival, while reducing oxidative stress and senescence, potentially preventing hypertension-induced heart damage.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Research
  • Pharmacology

Background:

  • Hypertension causes cardiac hypertrophy and failure, linked to oxidative stress and reduced cardiac stem cell (CSC) efficiency.
  • Maintaining CSC function is crucial for preventing progressive cardiac remodeling in heart disease.
  • The impact of cardioprotective antihypertensive drugs on CSCs remains largely unexplored.

Purpose of the Study:

  • To investigate the effects of metoprolol, a cardioprotective antihypertensive agent, on CSC function in spontaneously hypertensive rats (SHRs).
  • To determine if metoprolol can prevent the deterioration of CSC efficiency caused by hypertension.

Main Methods:

  • Spontaneously hypertensive rats (SHRs) were treated with metoprolol (50 mg/kg/day) for 2 months.
  • Cardiac stem cells (CSCs) were isolated from treated SHRs, untreated SHRs, and normotensive Wistar rats.
  • CSC migration, proliferation, differentiation, survival, oxidative stress, and senescence were evaluated.

Main Results:

  • SHRs exhibited decreased CSC migration and proliferation, and increased oxidative stress and senescence compared to Wistar rats.
  • Metoprolol treatment in SHRs significantly enhanced CSC migration and proliferation, and improved stemness retention.
  • Metoprolol-treated SHRs showed reduced cellular senescence and oxidative stress, with CSC attributes comparable to Wistar rats.

Conclusions:

  • Metoprolol treatment restores cardiac stem cell efficiency in hypertensive rats.
  • Improved CSC function is expected to mitigate hypertension-induced cardiac remodeling.
  • This study highlights a potential therapeutic mechanism for metoprolol in managing hypertensive heart disease.

Related Concept Videos

Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
4.3K
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
10.2K
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart...
2.8K
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.2K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
569
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K